EMEA-000171-PIP01-07 - paediatric investigation plan

glucosamine hydrochloride

chondroitin sulfate

Key facts

• Active substance:
  • glucosamine hydrochloride
  • chondroitin sulfate
• Therapeutic area:
  Immunology-Rheumatology-Transplantation
• Decision number:
  P/54/2008
• PIP number:
  EMEA-000171-PIP01-07
• Pharmaceutical form(s):
  • Capsule, hard
  • Granules in sachet
• Condition(s) / indication(s):
  Primary osteoarthritis
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  20/07/2008
• Compliance check done:
  Nee

Decision

P/54/2008: European medicines agency decision of 20 July 2008 on the application for product specific waiver for Glucosamine hydrochloride, chondroitin sulphate, PIP number EMEA-000171-PIP01-07 in accordance with Regula...

Adopted Reference Number: EMEA/363689/2008